| MolName | 1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(Z)-2,3-dihydroinden-1-ylideneamino]-5-(phenylsulfanylmethyl)triazole-4-carboxamide |
| MolecularFormula | C21H18N8O2S |
| Smiles | Nc1nonc1-n1nnc(C(N/N=C(/CC2)\c3c2cccc3)=O)c1CSc1ccccc1 |
| InChI | InChI=1S/C21H18N8O2S/c22-19-20(27-31-26-19)29-17(12-32-14-7-2-1-3-8-14)18(24-28-29)21(30)25-23-16-11-10-13-6-4-5-9-15(13)16/h1-9H,10-12H2,(H2,22,26)(H,25,30) |
| InChIK | RLVFJDOONYJICU-UHFFFAOYSA-N |
| TotalMolweight | 446.494 |
| Molweight | 446.494 |
| MonoisotopicMass | 446.127342 |
| CLogP | 4.0415 |
| CLogS | -4.56 |
| H Acceptors | 10 |
| H Donors | 2 |
| TotalSurfaceArea | 332.44 |
| Relative PSA | 0.40197 |
| PolarSurfaceArea | 162.41 |
| Druglikeness | 0.44627 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | acyl-hydrazone |
| Shape Index | 0.5 |
| Fragments | 1 |
| Non HAtoms | 32 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| Rotatable Bond | 6 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 22 |
| Sp3Atoms | 4 |
| Symmetricatoms | 2 |
| Aromatic Nitrogens | 5 |
| StereoCon |
Click to Load Molecule:
1 - 1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(Z)-2,3-dihydroinden-1-ylideneamino]-5-(phenylsulfanylmethyl)triazole-4-carboxamide | 2 - 1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(Z)-2,3-dihydroinden-1-ylideneamino]-5-(phenylsulfanylmethyl)triazole-4-carboxamide